A Closer Look at Decision-Making Process and the Potential of HTA for Health System Strengthening in Laos Nonthaburi, Thailand—April 30, 2025— A newly published study “Situation analysis of evidence-informed health decision-making in Lao PDR: the case of health technology assessm

January 29, 2025 – The Health Intervention and Technology Assessment Program (HITAP) Foundation participated in the Prince Mahidol Award Conference (PMAC) 2025, held from January 28 to February 2, 2025, in Bangkok, Thailand. This global event brought together health experts and leaders from the publ

On June 19, 2023, the Health Intervention and Technology Assessment Program Foundation (HITAP Foundation), in collaboration with the Saw Swee Hock School of Public Health of the National University of Singapore (NUS), organized a workshop on “Fruitful Research: How to Make Health Innovation Worthwhi

On behalf of the Health Intervention Technology and Assessment Program (HITAP) Foundation and the National University of Singapore (NUS), we have the pleasure of inviting you to participate in the “Fruitful Research: How to Make Health Innovation Worthwhile” Workshop and witness the Signing Ceremony

In the death of Professor Sir Mike David Rawlins, founding chairman of the National Institute for Health and Care Excellent (NICE), who passed away at 81, the world of health and social care guidance and medicine evaluation community has lost one of its greatest leaders. Over his

Nonthaburi, Thailand | November 25, 2022 – The Health Intervention and Technology Assessment Program (HITAP) announced the completion of the first Technical Workshop on Infectious Disease Modelling. Research staff from the London School of Hygiene and Tropical Medicine (LSHTM) with joint appointment

On 17th September 2018, Sarah Garner, coordinator of the Innovation, Access and Use team under the Essential Medicines and Health Products program, World Health Organization, had an informal meeting at the Health Intervention and Technology Assessment Program (HITAP). She was eager to learn about HI

(Reuters) – Swiss drugmaker Novartis told India’s top court it had demonstrated the improved efficacy of its cancer drug Glivec as the final hearing began on Tuesday of a patent case that could change the rules for the country’s healthcare sector.A patent would recognize Novartis’ property rights, i

(Reuters) – India’s highest court will hear final arguments starting this week in a landmark case over drug patents that could change the rules for the country’s healthcare sector and potentially curb its global role as a supplier of cut-price generic medicines.The Supreme Court hearing pits Swiss d

(Reuters) – Fewer people infected with HIV globally are dying as more of them get access to crucial antiretroviral drugs, particularly in sub-Saharan Africa, the United Nations AIDS program said on Wednesday.The United Nations estimates that about 34 million people are living with the human immunode